Cancer outcomes and biological mechanisms among patients with type 2 diabetes mellitus using glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis - Top-Institutions - MDSpire

Cancer outcomes and biological mechanisms among patients with type 2 diabetes mellitus using glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis

  • By

  • Ejike Daniel Eze

  • Leopold Ntakirutimana

  • Swase Dominic Terkimbi

  • Muluken Walle

  • Abdullahi Hussein Umar

  • Diresibachew Haile Wondimu

  • Makinde Vincent Olubiyi

  • Onyinye Cynthia Okeke

  • Olufunke Onaadepo

  • Jimoh Abdulazeez

  • David Chibuike Ikwuka

  • Elemi John Ani

  • Abdullateef Isiaka Alagbonsi

  • July 14, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Endocrinology
    • Oncology
  • #2

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Endocrinology
    • Pharmacoepidemiology
  • #3

    Virginia Commonwealth University
    Virginia Commonwealth University

    Richmond, Virginia

    Key Differentiators

    • Endocrinology
    • Research
  • #4

    Stanford University
    Stanford University

    Stanford, California

    Key Differentiators

    • Endocrinology
    • Research
  • #5

    Columbia University Irving Medical Center
    Columbia University Irving Medical Center

    New York, New York

    Key Differentiators

    • Endocrinology
    • Oncology

Original Source(s)

Related Content